News
Clinical Trials Arena on MSN1d
FDA clears CureVac’s IND application for Phase I lung cancer trialThe US Food and Drug Administration (FDA) has granted clearance to CureVac's investigational new drug application (IND) for ...
Vanda's strong financials and product lineup show promise, but management concerns and FDA disputes may hinder growth. Learn ...
CureVac (CVAC) announced that the U.S. Food and Drug Administration has cleared its Investigational New Drug application for a Phase 1 clinical ...
Zacks Investment Research on MSN6d
FDA Grants Accelerated Approval to NVS Kidney Disease DrugNovartis NVS obtains FDA approval of atrasentan, a potent and selective endothelin A (ETA) receptor antagonist, for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback